Non-canonical NOTCH3 signalling limits tumour angiogenesis

Lin, SH; Negulescu, A; Bulusu, S; Gibert, B; Delcros, JG; Ducarouge, B; Rama, N; Gadot, N; Treilleux, I; Saintigny, P; Meurette, O; Mehlen, P

Meurette, O; Mehlen, P (reprint author), Univ Lyon, Ctr Leon Berard, INSERM CNRS U1052 UMR5286,LabEx DEVweCAN, Ctr Rech Cancerol Lyon,Apoptosis Canc & Dev Lab,E, F-69008 Lyon, France.; Mehlen, P (reprint author), Ctr Leon Berard, Dept Translat Res & Innov

NATURE COMMUNICATIONS, 2017; 8 ( ):

Abstract

Notch signalling is a causal determinant of cancer and efforts have been made to develop targeted therapies to inhibit the so-called canonical pathway......

Full Text Link